PURPOSE OF TEST
The HEMOCHRON Signature Elite, ACT-LR is a quantitative assay for monitoring heparin anticoagulation during various medical procedures. The ACT-LR demonstrates linear correlation to the anticoagulation effects of heparin up to 2.5 units / ml of blood. It is intended for use in monitoring low to moderate heparin doses frequently employed in procedures such as cardiac catheterization, extracorporeal membrane oxygenation (ECMO), hemodialysis, and Percutaneous Transluminal Coronary Angioplasty (PTCA). The ACT-LR test is for in vitro diagnostic use and is for use with any model HEMOCHRON Whole Blood Microcoagulation System.
POLICY
SUPPLIES
HEMOCHRON Signature Elite, ACT-LR Testing Supplies
MANUFACTURER’S INFORMATION
IDA Pages (Clinical Indications, Documentation Plan, Clinical Actions)
Cardiac Cath Lab HG7 / Interventional Radiology Bldg 5, HB4, HG5 / OR HG7
INITIAL ORIENTATION, TRAINING & COMPETENCY
Initial Orientation & Training – This must be completed (once) with all new staff trained to use this test.
6 Methods of Competency – This must be completed by all testing personnel 1) After initial training and before technical duties are performed; 2) 6 months after initial training (California Law); and 3) annually thereafter.
Written Competency Test – This must be completed by all testing personnel 1) After initial training and before technical duties are performed; 2) 6 months after initial training (California Law); and 3) annually thereafter.
QUALITY CONTROL
TECHNICAL SUPPORT
For technical issues, contact Tech Support @ 732.548.5700
SAFETY DATA SHEETS (SDS)